ACADIA Pharmaceuticals (NasdaqGS:ACAD) 2025 Conference Transcript

ACADIA Pharmaceuticals (NasdaqGS:ACAD) 2025 Conference November 10, 2025 02:00 PM ET Speaker0Okay. Good day, everybody. Welcome to UBS Healthcare Conference. With us, we have Acadia Pharmaceuticals and Mark Schneehr, who is the Chief Financial Officer and Ponne Subbiah, who is the Chief Medical Officer. Thank you so much for joining us.My name is Ashwarmaikov, Smritcare Biotech and SpecPharma. So just want to go over the story and learn some of the exciting things Just for the audience in the room, if there ...